New trial aims to find best Pre-Surgery immunotherapy for advanced melanoma

NCT ID NCT06794775

Recruiting now Disease control Sponsor: Hildur Helgadottir Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 02, 2026 · Updated 19 times

Summary

This study compares two different immunotherapy drug combinations given before surgery to people with stage III melanoma that can be removed. The goal is to see which approach is better at preventing the cancer from coming back or spreading. About 128 adults will take part, and the trial is currently recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA STAGE III are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Karolinska University Hospital
RECRUITING

Stockholm, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Sahlgrenska University Hospital
RECRUITING

Gothenburg, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Skane University Hospital
RECRUITING

Lund, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MALIGNANT MELANOMA STAGE III